Thomas Lundbäck

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Antimicrobial agents and chemotherapy

SLAS discovery : advancing life sciences R & D

ACS chemical biology

Chemical science

AstraZeneca R&D Gothenburg

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca R&D Gothenburg Oct 25 2016

Sweden

Associate Director :: Discovery Sciences

GE Healthcare Jan 01 2009 - Mar 31 2010

Sweden

Senior Project Manager, Science Director :: Biotechnology

Biovitrum Jul 01 2001 - Dec 31 2008

Sweden

Section Manager, Project Leader, Principal Scientist :: Assay Development & Screening

Pharmacia & Upjohn Jan 01 1999 - Jun 30 2001

Sweden

Senior Scientist :: Structural Chemistry

Education History

Karolinska Institutet

Sweden

PHD :: Center for Structural Biochemistry

Royal Institute of Technology

Sweden

MSC :: Chemical Engineering

Publications

Masum Miah, Andrew M Davis, Charles Hannoun, Joanna S Said, Martina Fitzek, Marian Preston, Dave Smith, Colores Uwamariya, Ambjörn Kärmander, Thomas Lundbäck, Tomas Bergström, Edward Trybala
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrobial agents and chemotherapy 68 (3) (2024)
Masum Miah, Andrew M Davis, Charles Hannoun, Joanna S Said, Martina Fitzek, Marian Preston, Dave Smith, Colores Uwamariya, Ambjörn Kärmander, Thomas Lundbäck, Tomas Bergström, Edward Trybala
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrobial agents and chemotherapy 68 (3) (2024)
Masum Miah, Andrew M Davis, Charles Hannoun, Joanna S Said, Martina Fitzek, Marian Preston, Dave Smith, Colores Uwamariya, Ambjörn Kärmander, Thomas Lundbäck, Tomas Bergström, Edward Trybala
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrobial agents and chemotherapy 68 (3) (2024)
Masum Miah, Andrew M Davis, Charles Hannoun, Joanna S Said, Martina Fitzek, Marian Preston, Dave Smith, Colores Uwamariya, Ambjörn Kärmander, Thomas Lundbäck, Tomas Bergström, Edward Trybala
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrobial agents and chemotherapy 68 (3) (2024)
Masum Miah, Andrew M Davis, Charles Hannoun, Joanna S Said, Martina Fitzek, Marian Preston, Dave Smith, Colores Uwamariya, Ambjörn Kärmander, Thomas Lundbäck, Tomas Bergström, Edward Trybala
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrobial agents and chemotherapy (2024)
Masum Miah, Andrew M Davis, Charles Hannoun, Joanna S Said, Martina Fitzek, Marian Preston, Dave Smith, Colores Uwamariya, Ambjörn Kärmander, Thomas Lundbäck, Tomas Bergström, Edward Trybala
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrobial agents and chemotherapy 68 (3) (2024)
Cassandra L Fleming, Carlos Benitez-Martin, Elin Bernson, Yongjin Xu, Linnea Kristenson, Tord Inghardt, Thomas Lundbäck, Fredrik Bergh Thorén, Morten Grøtli, Joakim Andréasson
All-photonic kinase inhibitors: light-controlled release-and-report inhibition. Chemical science 15 (18) (2024)
Cassandra L Fleming, Carlos Benitez-Martin, Elin Bernson, Yongjin Xu, Linnea Kristenson, Tord Inghardt, Thomas Lundbäck, Fredrik Bergh Thorén, Morten Grøtli, Joakim Andréasson
All-photonic kinase inhibitors: light-controlled release-and-report inhibition. Chemical science 15 (18) (2024)
Mateusz P Plesniak, Emilia K Taylor, Frederik Eisele, Christopher M B K Kourra, Iacovos N Michaelides, Alice Oram, Johan Wernevik, Zulma Santisteban Valencia, Hannah Rowbottom, Nadia Mann, Linda Fredlund, Valentyna Pivnytska, Anna Novén, Mohammad Pirmoradian, Thomas Lundbäck, R Ian Storer, Mariell Pettersson, Gian M De Donatis, Marie Rehnström
Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures. ACS medicinal chemistry letters 14 (12) (2023)
Mateusz P Plesniak, Emilia K Taylor, Frederik Eisele, Christopher M B K Kourra, Iacovos N Michaelides, Alice Oram, Johan Wernevik, Zulma Santisteban Valencia, Hannah Rowbottom, Nadia Mann, Linda Fredlund, Valentyna Pivnytska, Anna Novén, Mohammad Pirmoradian, Thomas Lundbäck, R Ian Storer, Mariell Pettersson, Gian M De Donatis, Marie Rehnström
Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures. ACS medicinal chemistry letters 14 (12) (2023)
Tatiana A Giovannucci, Florian A Salomons, Martin Haraldsson, Lotta H M Elfman, Malin Wickström, Patrick Young, Thomas Lundbäck, Jürgen Eirich, Mikael Altun, Rozbeh Jafari, Anna-Lena Gustavsson, John Inge Johnsen, Nico P Dantuma
Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound. Cell death & disease 12 (10) (2021)
Johan Wernevik, Johan Hulthe, Cameron McPheat, Silvio Di Castro, Thomas Lundbäck
Letter to the Editor: Implementation of Acoustic Dispensing and 384-Well Based Workflows to Improve Assay Capacity and Reduce Compound and Solvent Use in Early Drug Metabolism and Pharmacokinetics Profiling. Assay and drug development technologies 19 (7) (2021)
Yongjin Xu, Chunxia Gao, Liliana Håversen, Thomas Lundbäck, Joakim Andréasson, Morten Grøtli
Design and development of a photoswitchable DFG-out kinase inhibitor. Chemical communications (Cambridge, England) 57 (78) (2021)
Karin Engen, Sudarsana Reddy Vanga, Thomas Lundbäck, Faith Agalo, Vivek Konda, Annika Jenmalm Jensen, Johan Åqvist, Hugo Gutiérrez-de-Terán, Mathias Hallberg, Mats Larhed, Ulrika Rosenström
Synthesis, Evaluation and Proposed Binding Pose of Substituted Spiro-Oxindole Dihydroquinazolinones as IRAP Inhibitors. ChemistryOpen 9 (3) (2020)
Kavitha Siva, Fredrik Ek, Jun Chen, Abdul Ghani Alattar, Kristmundur Sigmundsson, Roger Olsson, Marcin Wlodarski, Thomas Lundbäck, Johan Flygare
A Phenotypic Screening Assay Identifies Modulators of Diamond Blackfan Anemia. SLAS discovery : advancing life sciences R & D 24 (3) (2020)
Si Min Zhang, Matthieu Desroses, Anna Hagenkort, Nicholas C K Valerie, Daniel Rehling, Megan Carter, Olov Wallner, Tobias Koolmeister, Adam Throup, Ann-Sofie Jemth, Ingrid Almlöf, Olga Loseva, Thomas Lundbäck, Hanna Axelsson, Shruti Regmi, Antonio Sarno, Andreas Krämer, Linda Pudelko, Lars Bräutigam, Azita Rasti, Mona Göttmann, Elisée Wiita, Juliane Kutzner, Michaela Arndt, Christina Kalderén, Armando Cázares-Körner, Brent D G Page, Rosa Krimpenfort, Saeed Eshtad, Mikael Altun, Sean G Rudd, Stefan Knapp, Martin Scobie, Evert J Homan, Ulrika Warpman Berglund, Pål Stenmark, Thomas Helleday
Development of a chemical probe against NUDT15. Nature chemical biology 16 (10) (2020)
Brinton Seashore-Ludlow, Hanna Axelsson, Thomas Lundbäck
Perspective on CETSA Literature: Toward More Quantitative Data Interpretation. SLAS discovery : advancing life sciences R & D 25 (2) (2019)
Aarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson, Arjan Snijder, Niek Dekker, Dean G Brown, Thomas Lundbäck, Andrew X Zhang, M Paola Castaldi
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins. ACS chemical biology 14 (9) (2019)
Brinton Seashore-Ludlow, Hanna Axelsson, Helena Almqvist, Björn Dahlgren, Mats Jonsson, Thomas Lundbäck
Quantitative Interpretation of Intracellular Drug Binding and Kinetics Using the Cellular Thermal Shift Assay. Biochemistry 57 (48) (2018)
Jakub Stefaniak, Andrew M Lewis, Daniel Conole, Sébastien R G Galan, Carole J R Bataille, Graham M Wynne, M Paola Castaldi, Thomas Lundbäck, Angela J Russell, Kilian V M Huber
Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors. ACS chemical biology 13 (10) (2018)

Thomas Lundbäck.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Lundbäck